American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.
The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.
Saslow
Debbie
D
Cancer Control Science Department, American Cancer Society, Altanta, GA, USA.
Castle
Philip E
PE
Cox
J Thomas
JT
Davey
Diane D
DD
Einstein
Mark H
MH
Ferris
Daron G
DG
Goldie
Sue J
SJ
Harper
Diane M
DM
Kinney
Walter
W
Moscicki
Anna-Barbara
AB
Noller
Kenneth L
KL
Wheeler
Cosette M
CM
Ades
Terri
T
Andrews
Kimberly S
KS
Doroshenk
Mary K
MK
Kahn
Kelly Green
KG
Schmidt
Christy
C
Shafey
Omar
O
Smith
Robert A
RA
Partridge
Edward E
EE
Garcia
Francisco
F
D000570:American Cancer Society; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000592:standards*; D008297:Male; D030361:Papillomavirus Infections / Q000473:pathology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011230:Precancerous Conditions / Q000473:pathology / Q000517:prevention & control* / Q000821:virology; D011315:Preventive Medicine / Q000592:standards*; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology
D053918:Papillomavirus Vaccines